Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Sustainable production of radionuclidically pure antimony-119

Journal Article · · EJNMMI Radiopharmacy and Chemistry
Background Radiopharmaceutical therapy (RPT) uses radionuclides that decay via one of three therapeutically relevant decay modes (alpha, beta, and internal conversion (IC) / Auger electron (AE) emission) to deliver short range, highly damaging radiation inside of diseased cells, maintaining localized dose distribution and sparing healthy cells. Antimony-119 (119Sb, t1/2 = 38.19 h, EC = 100%) is one such IC/AE emitting radionuclide, previously limited to in silico computational investigation due to barriers in production, chemical separation, and chelation. A theranostic (therapeutic/diagnostic) pair can be formed with 119Sb’s radioisotopic imaging analogue 117Sb (t1/2 = 2.80 h, Eγ = 158.6 keV, Iγ = 85.9%, β+ = 262.4 keV, Iβ+ = 1.81%). Results Within, we report techniques for sustainable and cost-effective production of pre-clinical quality and quantity, radionuclidically pure 119Sb and 117Sb, novel low energy photon measurement techniques for 119Sb activity determination, and physical yields for various tin target isotopic enrichments and thicknesses using (p, n) and (d, n) nuclear reactions. Additionally, we present a two-column separation providing a radioantimony yield of 73.1% ± 6.9% (N = 3) and tin separation factor of (6.8 ± 5.5) x 105 (N = 3). Apparent molar activity measurements for deuteron produced 117Sb using the chelator TREN-CAM were measured at 42.4 ± 25 MBq 117Sb/µmol (1.14 ± 0.68 mCi/µmol), and we recovered enriched 119Sn target material at a recycling efficiency of 80.2% ± 5.5% (N = 6) with losses of 11.6 mg ± 0.8 mg (N = 6) per production. Conclusion We report significant steps in overcoming barriers in 119Sb production, chemical isolation and purification, enriched target material recycling, and chelation, helping promote accessibility and application of this promising therapeutic radionuclide. We describe a method for 119Sb activity measurement using its low energy gamma (23.87 keV), negating the need for attenuation correction. Finally, we report the largest yet-measured 119Sb production yields using proton and deuteron irradiation of natural and enriched targets and radioisotopic purity > 99.8% at end of purification.
Research Organization:
University of Wisconsin, Madison, WI (United States)
Sponsoring Organization:
USDOE; USDOE Office of Science (SC), Office of Isotope R&D and Production (IRP)
Grant/Contract Number:
SC0022032; SC0023012
OSTI ID:
2473158
Alternate ID(s):
OSTI ID: 2475630
Journal Information:
EJNMMI Radiopharmacy and Chemistry, Journal Name: EJNMMI Radiopharmacy and Chemistry Journal Issue: 1 Vol. 9; ISSN 2365-421X
Publisher:
BioMed CentralCopyright Statement
Country of Publication:
United States
Language:
English

References (20)

“Off‐Label Use” of the Siderophore Enterobactin Enables Targeted Imaging of Cancer with Radioactive Ti(IV) journal March 2024
Chemistry of Antimony in Radiopharmaceutical Development: Unlocking the Theranostic Potential of Sb Isotopes journal October 2024
Nuclear Data Sheets for A = 117 journal March 2002
Tissue sulfhydryl groups journal May 1959
Production of the Auger emitter 119Sb for targeted radionuclide therapy using a small PET-cyclotron journal January 2009
Medium to large scale radioisotope production for targeted radiotherapy using a small PET cyclotron journal January 2011
Nuclear Data Sheets for A = 119 journal November 2009
TENDL: Complete Nuclear Data Library for Innovative Nuclear Science and Technology journal January 2019
Improved production of 76Br, 77Br and 80mBr via CoSe cyclotron targets and vertical dry distillation journal January 2020
Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations journal March 2021
Catechol-Based Functionalizable Ligands for Gallium-68 Positron Emission Tomography Imaging journal August 2020
A Third Generation Potentially Bifunctional Trithiol Chelate, Its nat,1XX Sb(III) Complex, and Selective Chelation of Radioantimony ( 119 Sb) from Its Sn Target journal October 2021
Low-energy Electron Emitters for Targeted Radiotherapy of Small Tumours journal January 2001
Fityk : a general-purpose peak fitting program journal September 2010
Sb119-A potent Auger emitter for targeted radionuclide therapy: Sb119-A potent Auger emitter for radionuclidetherapy journal August 2008
Auger electrons for cancer therapy – a review journal October 2019
Definitions of radioisotope thick target yields journal January 2015
Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119. journal November 2021
Monte Carlo Evaluation of Auger Electron–Emitting Theranostic Radionuclides journal July 2015
Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy journal August 2023

Similar Records

A Third Generation Potentially Bifunctional Trithiol Chelate, Its nat,1XXSb(III) Complex, and Selective Chelation of Radioantimony (119Sb) from Its Sn Target
Journal Article · Sun Oct 03 20:00:00 EDT 2021 · Inorganic Chemistry · OSTI ID:1846100

Formation of medical radioisotopes {sup 111}In, {sup 117m}Sn, {sup 124}Sb, and {sup 177}Lu in photonuclear reactions
Journal Article · Mon Jun 15 00:00:00 EDT 2015 · Physics of Atomic Nuclei · OSTI ID:22472285